72 minutes | Jul 6, 2021

How do you develop a T-cell therapy to prevent organ transplant rejection?

Emma Morris and Iain McGill uncover the fascinating story behind Quell Therapeutics, revealing how a team of 6 top scientists came together to develop a pioneering cell and gene therapy that harnesses the body's immune response to prevent life-threatening organ transplant rejection. In this episode, we cover the cutting-edge science, top trends in precision medicine, and what it takes to build a successful biotech in just 2 years.
Play
Like
Play Next
Mark
Played
Share